Prime Medicine
Prime Medicine is a clinical-stage biotechnology company developing a new class of differentiated one-time curative genetic therapies built on Prime Editing, a versatile, precise, and efficient gene editing technology that can search and replace disease-causing genetic sequences at their precise location in the genome without causing double-strand DNA breaks. The company is advancing a pipeline of programs across a broad range of diseases and, per its public materials, believes Prime Editing could theoretically correct approximately 90% of known disease-causing genetic mutations. It is publicly traded and surfaced in the API Evangelist network as a portfolio company of GV (Google Ventures). This is a corporate/life-sciences profile: the company publishes no public developer API, developer portal, or API documentation.
Prime Medicine is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Gene Editing, and Prime Editing.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Other 2
Properties that don't map to a standard resource type